New hope for hard-to-treat lung cancer: targeted drugs before surgery

This study tests whether giving targeted drugs before surgery can help people with stage III lung cancer that has rare gene changes. About 120 adults who have not had treatment will receive a drug matched to their tumor's mutation, then doctors will check if the tumor becomes removable. The goal is to see if this approach can shrink tumors enough for surgery and improve long-term outcomes.